CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing demand for drug discovery and pharmacogenomics
4.1.2. Technological advancements
4.1.3. Rising incidence of infectious diseases and genetic disorders
4.1.4. Growing public-private investments, funds, and grants
4.1.5. Growing geriatric population
4.2. Market Restraints & Challenges
4.2.1. Adoption and application of MIQE guidelines for publishing qPCR-based research
4.2.2. Technical limitations associated with qPCR
4.2.3. High setting-up and reagents refill costs
4.3. Market Opportunities
4.3.1. Increase in M&A and internal restructuring in life science industries
4.3.2. The shift from plant-derived to genome-based drug discovery
CHAPTER 5 GLOBAL qPCR REAGENTS MARKET – BY DETECTION METHOD
5.1. Dye-Based qPCR Reagents
5.2. Probes and Primer-Based qPCR Reagents
CHAPTER 6 GLOBAL qPCR REAGENTS MARKET – BY PACKAGING TYPE
6.1. qPCR Core Kits
6.2. qPCR Master mixes
CHAPTER 7 GLOBAL qPCR REAGENTS MARKET – BY APPLICATION
7.1. Diagnostic Applications
7.2. Research Applications
7.3. Forensic Applications
CHAPTER 8 GLOBAL qPCR REAGENTS MARKET – BY END USER
8.1. Hospitals & Diagnostic Centers
8.2. Research Laboratories & Academic Institutes
8.3. Pharmaceutical & Biotechnology Companies
8.4. Clinical Research Organizations
8.5. Forensic Laboratories
CHAPTER 9 GLOBAL qPCR REAGENTS MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL qPCR REAGENTS MARKET - COMPANY PROFILES
10.1. Bio-Rad Laboratories
10.2. Thermo Fisher Scientific, Inc.
10.3. Qiagen NV
10.4. F. Hoffman-La Roche
10.5. Agilent Technologies
10.6. Takara Bio
10.7. Affymetrix
10.8. Promege Corporation
10.9. Sigma-Aldrich Corporation
10.10. Quanta Biosciences
10.11. Merck Millipore
10.12. GE Healthcare
10.13. Danaher Corporation
10.14. Perkin Elmer, Inc.
10.15. Abbott Laboratories Inc.
CHAPTER 11 GLOBAL qPCR REAGENTS MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
